AGLE

Aeglea BioTherapeutics, Inc. [AGLE] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

AGLE Stock Summary

In the News

AGLE Financial details

Company Rating
-
Market Cap
48.63M
Income
-294.43M
Revenue
1.05M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
69
Optionable
No
Shortable
Yes
Earnings
04 Mar 2024
P/E
-0.18
Forward P/E
-
PEG
-0.01
P/S
46.14
P/B
-0.21
P/C
-
P/FCF
-0.56
Quick Ratio
4.54
Current Ratio
4.59
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-71.22
EPS next Y
-
EPS next Q
-
EPS this Y
-0.64%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-14.13%
Revenue last 5Y
-9.74%
Revenue Q/Q
-
EPS Q/Q
-83.55%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-142%
ROE
319%
ROC
-1.33%
Gross Margin
100%
Oper. Margin
-20451%
Profit Margin
-27935%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.66-24.0
52W High
-
52W Low
-
RSI
50
Rel Volume
0.73
Avg Volume
59.54K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
2.572
-
-
Volatility
3.44%, 3.44%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
Same Sector
Similar Market Cap